Close Menu

supply agreement

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Rubicon Genomics has signed an agreement to provide Kreatech Diagnostics with its OmniPlex-D whole-genome amplification technology.

Agendia will use Rubicon Genomics' whole-genome RNA amplification technology in its breast cancer diagnostic tests, Rubicon said today.

By integrating the STR reagents into the RapidHit System, human DNA profiles can be generated that are compatible with local, national, and international database systems, the companies said.

The Department of Cancer Immunology and AIDS at Dana-Farber will use the synthetic biology platform as part of research to develop transient immunity against life-threatening viral infections.

The firms have formalized a supply deal, under which Sequenom and its subsidiaries will purchase Illumina sequencing products for use in developing its non-invasive trisomy 21 test.

Scienion will produce protein microarray batches of more than 1,000 arrays for Protagen for the clinical validation of biomarker panels.

The two-year agreement, which took effect in March 2009 to substantiate CDI's iCell Cardiomyocytes as a predictive tool, was completed early, and the platform will now be incorporated into Roche's drug development decision-making process.

IMDx received access to patents covering Biosearch's BHQ, CAL Fluor, and Quasar technologies.

The firm will be a preferred supplier of synthetic oligonucleotides to Research Councils UK Shared Services Centre Ltd.

Pages

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.